Clinical Trial Update: Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors [Phase 1]

View source ↗

Summary

An ongoing Phase 1 trial is evaluating BL-M05D1 in patients with solid tumors, assessing safety, tolerability, pharmacokinetics, and preliminary efficacy across…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Esophageal Adenocarcinoma
• Gastric Adenocarcinoma
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• BL-M05D1

Snippet

Sponsor: SystImmune Inc. | Conditions: Gastric Adenocarcinoma, Advanced Pancreatic Ductal Adenocarcinoma | Phase 1 | Status: RECRUITING